Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$NRIX Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $4.73 up 559.22% YoY
• Reported revenue of $673.06M up 8430.54% YoY
• Nurix expects existing cash, cash equivalents and marketable securities of $1.1B to fund operations, including clinical trials and infrastructure, for at least the next 12 months; additional funding will be needed.